Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Related Posts
Irannejad K, Mafi M, Krishnan S, Budoff MJ. Artificial intelligence in coronary CT angiography: transforming the diagnosis and risk stratification of atherosclerosis. Int J Cardiovasc[...]
Tol MJ, Shimanaka Y, Bedard AH, Sapia J, Cui L, Colaço-Gaspar M, Hofer P, Ferrari A, Qian K, Kennelly JP, Lee SD, Gao Y, Xiao[...]
Witte O, Radu C, Czernin J. Changing Career Focus: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and[...]